Hinge Health Inc. (NYSE:HNGE) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Hinge Health Inc. (NYSE:HNGE) have earned an average rating of “Moderate Buy” from the nineteen analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $59.9333.

A number of equities research analysts recently commented on HNGE shares. Morgan Stanley increased their price target on Hinge Health from $57.00 to $67.00 and gave the company an “overweight” rating in a research report on Tuesday, September 23rd. Stifel Nicolaus increased their price objective on shares of Hinge Health from $63.00 to $66.00 and gave the company a “buy” rating in a research note on Thursday, September 11th. Evercore ISI lifted their target price on shares of Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Canaccord Genuity Group upped their target price on Hinge Health from $61.00 to $65.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Finally, Bank of America lifted their price target on Hinge Health from $42.00 to $64.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Hinge Health in the 3rd quarter worth approximately $37,000. Montag A & Associates Inc. purchased a new stake in Hinge Health in the second quarter worth $41,000. Jones Financial Companies Lllp lifted its position in shares of Hinge Health by 348.0% during the 3rd quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after buying an additional 870 shares during the last quarter. SBI Securities Co. Ltd. purchased a new position in shares of Hinge Health during the 2nd quarter valued at $48,000. Finally, Aster Capital Management DIFC Ltd bought a new position in shares of Hinge Health during the 3rd quarter worth $49,000.

Hinge Health Price Performance

NYSE HNGE opened at $42.24 on Thursday. The company has a fifty day simple moving average of $51.66. Hinge Health has a 12-month low of $33.42 and a 12-month high of $62.18.

Hinge Health (NYSE:HNGE) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The business had revenue of $154.21 million during the quarter, compared to the consensus estimate of $142.44 million. The firm’s revenue for the quarter was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health declared that its board has authorized a stock buyback plan on Wednesday, November 12th that authorizes the company to buyback $250.00 million in shares. This buyback authorization authorizes the company to reacquire up to 7.2% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.